Replies to post #18516 on Biotech Values

[DewDiligence]

>gvax - Didn't they have good results in pancreatic cancer years ago? If so what slowed them down?<

The GVAX program has had manifold incarnations—almost too many to count—including both patient-specific and off-the-shelf varieties.